Search | VHL CLAP/WR-PAHO/WHO

1.

Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts.

Ljung, Rolf; de Kovel, Marloes; van den Berg, H Marijke.

Haemophilia ; 29(2): 498-504, 2023 Mar.

Article in English | MEDLINE | ID: mdl-36571801

2.

Hemostasis - A Balancing Act.

van den Berg, H Marijke; Srivastava, Alok.

N Engl J Med ; 389(9): 853-856, 2023 Aug 31.

Article in English | MEDLINE | ID: mdl-37646683

3.

Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry-based study.

Jonker, Carla J; Oude Rengerink, Katrien; Hoes, Arno W; Mol, Peter G M; van den Berg, H Marijke.

Haemophilia ; 26(5): 809-816, 2020 Sep.

Article in English | MEDLINE | ID: mdl-32627880

4.

Registries supporting new drug applications.

Jonker, Carla J; van den Berg, H Marijke; Kwa, Marcel S G; Hoes, Arno W; Mol, Peter G M.

Pharmacoepidemiol Drug Saf ; 26(12): 1451-1457, 2017 Dec.

Article in English | MEDLINE | ID: mdl-28983992

5.

Factor VIII products and inhibitor development in severe hemophilia A.

Gouw, Samantha C; van der Bom, Johanna G; Ljung, Rolf; Escuriola, Carmen; Cid, Ana R; Claeyssens-Donadel, Ségolène; van Geet, Christel; Kenet, Gili; Mäkipernaa, Anne; Molinari, Angelo Claudio; Muntean, Wolfgang; Kobelt, Rainer; Rivard, George; Santagostino, Elena; Thomas, Angela; van den Berg, H Marijke.

N Engl J Med ; 368(3): 231-9, 2013 Jan 17.

Article in English | MEDLINE | ID: mdl-23323899

6.

Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A.

van den Berg, H Marijke; Fischer, Kathelijn; Carcao, Manuel; Chambost, Hervé; Kenet, Gili; Kurnik, Karin; Königs, Chris; Male, Christoph; Santagostino, Elena; Ljung, Rolf.

Blood ; 134(3): 317-320, 2019 07 18.

Article in English | MEDLINE | ID: mdl-31186271

7.

Different impact of factor VIII products on inhibitor development?

van den Berg, H Marijke.

Thromb J ; 14(Suppl 1): 31, 2016.

Article in English | MEDLINE | ID: mdl-27766057

8.

A Cure for Hemophilia within Reach.

van den Berg, H Marijke.

N Engl J Med ; 377(26): 2592-2593, 2017 12 28.

Article in English | MEDLINE | ID: mdl-29224412

9.

Assessment of clotting factor concentrates--pivotal studies and long-term requirements.

van den Berg, H Marijke; Peyvandi, Flora.

Semin Thromb Hemost ; 41(8): 855-9, 2015 Nov.

Article in English | MEDLINE | ID: mdl-26479895

10.

Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A.

Carcao, Manuel D; van den Berg, H Marijke; Ljung, Rolf; Mancuso, Maria Elisa.

Blood ; 121(19): 3946-52, S1, 2013 May 09.

Article in English | MEDLINE | ID: mdl-23482934

11.

Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s.

Fischer, Kathelijn; Steen Carlsson, Katarina; Petrini, Pia; Holmström, Margareta; Ljung, Rolf; van den Berg, H Marijke; Berntorp, Erik.

Blood ; 122(7): 1129-36, 2013 Aug 15.

Article in English | MEDLINE | ID: mdl-23777770

12.

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.

Gouw, Samantha C; van den Berg, H Marijke; Fischer, Kathelijn; Auerswald, Günter; Carcao, Manuel; Chalmers, Elizabeth; Chambost, Hervé; Kurnik, Karin; Liesner, Ri; Petrini, Pia; Platokouki, Helen; Altisent, Carmen; Oldenburg, Johannes; Nolan, Beatrice; Garrido, Rosario Pérez; Mancuso, M Elisa; Rafowicz, Anne; Williams, Mike; Clausen, Niels; Middelburg, Rutger A; Ljung, Rolf; van der Bom, Johanna G.

Blood ; 121(20): 4046-55, 2013 May 16.

Article in English | MEDLINE | ID: mdl-23553768

13.

WFH Guidelines for the Management of Hemophilia, 3rd edition.

Srivastava, Alok; Santagostino, Elena; Dougall, Alison; Kitchen, Steve; Sutherland, Megan; Pipe, Steven W; Carcao, Manuel; Mahlangu, Johnny; Ragni, Margaret V; Windyga, Jerzy; Llinás, Adolfo; Goddard, Nicholas J; Mohan, Richa; Poonnoose, Pradeep M; Feldman, Brian M; Lewis, Sandra Zelman; van den Berg, H Marijke; Pierce, Glenn F.

Haemophilia ; 26 Suppl 6: 1-158, 2020 Aug.

Article in English | MEDLINE | ID: mdl-32744769

14.

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.

Gouw, Samantha C; van den Berg, H Marijke; Oldenburg, Johannes; Astermark, Jan; de Groot, Philip G; Margaglione, Maurizio; Thompson, Arthur R; van Heerde, Waander; Boekhorst, Jorien; Miller, Connie H; le Cessie, Saskia; van der Bom, Johanna G.

Blood ; 119(12): 2922-34, 2012 Mar 22.

Article in English | MEDLINE | ID: mdl-22282501

15.

Can a "center effect" explain the higher frequency of inhibitors for a second-generation recombinant factor VIII product?

van den Berg, H Marijke; Ljung, Rolf.

Blood ; 126(18): 2164-5, 2015 Oct 29.

Article in English | MEDLINE | ID: mdl-26392597

16.

Factor VIII products and inhibitors in severe hemophilia A.

van den Berg, H Marijke; Gouw, Samantha C; van der Bom, Johanna G.

N Engl J Med ; 368(15): 1457, 2013 04 11.

Article in English | MEDLINE | ID: mdl-23574131

17.

A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A.

Fischer, Kathelijn; Pouw, Maurice E; Lewandowski, Daniel; Janssen, Mart P; van den Berg, H Marijke; van Hout, Ben A.

Haematologica ; 96(5): 738-43, 2011 May.

Article in English | MEDLINE | ID: mdl-21273268

18.

Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders.

Jonker, Carla J; de Vries, Sieta T; van den Berg, H Marijke; McGettigan, Patricia; Hoes, Arno W; Mol, Peter G M.

Drug Saf ; 44(8): 853-861, 2021 08.

Article in English | MEDLINE | ID: mdl-34091881

19.

Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo.

van Schooten, Carina J; Shahbazi, Shirin; Groot, Evelyn; Oortwijn, Beatrijs D; van den Berg, H Marijke; Denis, Cécile V; Lenting, Peter J.

Blood ; 112(5): 1704-12, 2008 Sep 01.

Article in English | MEDLINE | ID: mdl-18559674

20.

Factor VIII-specific B cell responses in haemophilia A patients with inhibitors.

van Helden, P M W; Van Haren, S D; Fijnvandraat, K; van den Berg, H Marijke; Voorberg, J.

Haemophilia ; 16(102): 35-43, 2010 May.

Article in English | MEDLINE | ID: mdl-20536984

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Config filters

Your selection (0)

Export format:

Export: